K-21 v3

Natural health product licensed in Canada

Other names: K-21, Knutric
Licence holder: Immunotec Inc.
NPN or DIN-HM: 80115284
Status: Active licence
Licence date: 6 January 2022
Revision date: 10 March 2025
Form: Liquide oral
Route of administration: Orale
Application type: Générale (non traditionelle)

If this product were sold in France

Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source	Maximum per day, adult
Medicago sativa Source : Medicago sativa- Sommité (herbe) Extract : Matériel brut sec Extraction ratio : 4.5:1 Dry plant equivalent : 37.8 mg	8.4 mg	Not calculated
Magnésium Source : Citrate de magnésium	11 mg	Not calculated
Bore Source : Citrate de bore	100 microgram	Not calculated
Thymus vulgaris Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 33.6 mg	8.4 mg	Not calculated
Brassica oleracea var. italica Source : Brassica oleracea var. italica - plante entière	2 mg	Not calculated
Euterpe oleracea Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 10 mg	2 mg	Not calculated
Vaccinium macrocarpon Extract : Matériel brut sec Extraction ratio : 12:1 Dry plant equivalent : 24 mg Potency : 1 % Proanthocyanidins	2 mg	Not calculated
Vaccinium macrocarpon Extract : Matériel brut sec Extraction ratio : 26:1 Dry plant equivalent : 52 mg	Not specified	Not calculated

Non-medicinal ingredients

Sucre de betterave, Dextrose de culture, D-Fructose, Hydroxyde de magnésium, Maltodextrine, Hexamétaphosphate de sodium, Acide citrique, Dextrine, Gomme de xanthane, Eau purifiée, Phosphate de tricalcium, Jus de fruits, Benzoate de sodium, Extrait de feuilles de stévia, Citrate de potassium, Inuline, Glycérine, Saveur

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Adultes	minimum: 18 years	1 Cuillière(s) à table	1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Source of Iodine and Potassium, factors in the maintenance of good health. Source of Iodine and Potassium, factors in normal growth and development. Source of Iodine and Potassium to support biological functions which play a key role in the maintenance of good health. Maintains good health. Supports good health. Contributes to maintaining general health. For maintaining general health. A factor in the maintenance of good health. Iodine and Potassium supplement. Helps in the function of the thyroid gland. Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of fungal polysaccharides with immunomodulating properties.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.